Skip to content
Citation only via Europe PMC

Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer's disease clinical spectrum.

Feng Y, Sha Y, Xu L, Tian J, Gao Y, Zhou R, Liu G.

Frontiers in aging neuroscience · 2026

Abstract

<h4>Background</h4>Gut microbiome alterations have been associated with Alzheimer's disease (AD), but how microbial composition, fecal metabolites, and cognitive function relate across the cognitive impairment spectrum-from subjective cognitive decline (SCD) through mild cognitive impairment (MCI) to AD-remains unclear. We integrated microbiome and metabolome profiles across this clinical spectrum.<h4>Methods</h4>Fecal samples from 84 participants [10 healthy controls (HC), 22 SCD, 23 MCI, 29 AD] underwent 16S rRNA V3-V4 sequencing and untargeted LC-MS metabolomics. Profiles were integrated via Procrustes analysis, sparse canonical correlation, MIMOSA2 community-metabolism modeling, and mediation analysis. Differential abundance was assessed by Kruskal-Wallis, ANCOM-BC2, and LinDA.<h4>Results</h4>Microbial composition differed across groups (ANOSIM <i>R</i> = 0.111, <i>p</i> = 0.001; Adonis <i>R</i> <sup>2</sup> = 0.070, <i>p</i> = 0.002). Cross-method validation confirmed 8 differentially abundant genera in AD vs. HC with 100% directional concordance between ANCOM-BC2 and LinDA, including depletion of butyrate-producing Lachnospiraceae (Blautia, Dorea, Fusicatenibacter) and enrichment of opportunistic pathobionts (Klebsiella, Escherichia-Shigella). Taurine showed the highest MIMOSA2 community-prediction <i>R</i> <sup>2</sup> (0.129; <i>n</i> = 62) and was positively associated with MMSE scores (<i>r</i> = 0.45, BH-FDR <i>Q</i> = 0.0005). A multi-omic random forest model (5 genera + 5 metabolites + age + sex) discriminated AD-clinical spectrum participants from HC with AUC = 0.86 (95% CI 0.82-0.90), although pairwise differences from the age + sex baseline (AUC = 0.75) did not reach statistical significance. Statistical mediation analysis was consistent with a Blautia → taurine → MMSE statistical mediation [ACME = 0.21, <i>p</i> = 0.008; 54% proportion mediated, bootstrap 95% CI (9%, 58%)].<h4>Conclusion</h4>Integrated multi-omic profiling reveals coordinated microbiome-metabolome dysregulation across the AD clinical spectrum, with taurine as a candidate microbial-metabolic node linking gut dysbiosis to cognitive performance. Microbial and metabolic alterations are detectable at the SCD stage, before objective cognitive impairment. These findings warrant validation in larger, age-matched cohorts and higher-resolution metagenomic studies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3389/fnagi.2026.1981076
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Y, F., Y, S., L, X., J, T., Y, G., R, Z., &amp; G., L. (2026). Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer's disease clinical spectrum. <em>Frontiers in aging neuroscience</em>. https://doi.org/10.3389/fnagi.2026.1981076
Vancouver
Y F, Y S, L X, J T, Y G, R Z, et al. Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer's disease clinical spectrum. Frontiers in aging neuroscience. 2026. doi:10.3389/fnagi.2026.1981076.
BibTeX
@article{feng2026Integr, title = {Integrated gut microbiome and fecal metabolome profiling identifies taurine-associated microbial dysbiosis across the Alzheimer's disease clinical spectrum.}, author = {Feng Y and Sha Y and Xu L and Tian J and Gao Y and Zhou R and Liu G.}, journal = {Frontiers in aging neuroscience}, year = {2026}, doi = {10.3389/fnagi.2026.1981076}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings